Correlation Between GlaxoSmithKline PLC and Hcm Income

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Hcm Income at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Hcm Income into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Hcm Income Plus, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Hcm Income and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Hcm Income. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Hcm Income.

Diversification Opportunities for GlaxoSmithKline PLC and Hcm Income

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and Hcm is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Hcm Income Plus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hcm Income Plus and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Hcm Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hcm Income Plus has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Hcm Income go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Hcm Income

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Hcm Income. In addition to that, GlaxoSmithKline PLC is 1.14 times more volatile than Hcm Income Plus. It trades about -0.33 of its total potential returns per unit of risk. Hcm Income Plus is currently generating about 0.09 per unit of volatility. If you would invest  1,790  in Hcm Income Plus on August 27, 2024 and sell it today you would earn a total of  39.00  from holding Hcm Income Plus or generate 2.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Hcm Income Plus

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Hcm Income Plus 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Hcm Income Plus are ranked lower than 8 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical and fundamental indicators, Hcm Income may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Hcm Income Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Hcm Income

The main advantage of trading using opposite GlaxoSmithKline PLC and Hcm Income positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Hcm Income can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hcm Income will offset losses from the drop in Hcm Income's long position.
The idea behind GlaxoSmithKline PLC ADR and Hcm Income Plus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance